Are Wall Street Analysts Predicting Marsh & McLennan Stock Will Climb or Sink?

Headquartered in New York, Marsh & McLennan Companies, Inc. (MMC) is a leading global professional services firm operating in over 130 countries with nearly 90,000 employees. Valued at a market cap of $103.8 billion, the company delivers risk management, insurance and reinsurance brokerage, talent and benefits consulting, and management consulting through its four major subsidiaries, Marsh, Guy Carpenter, Mercer, and Oliver Wyman.

MMC shares have lagged the broader market over the past year, dropping 5.9% compared to the S&P 500 Index ($SPX) 13.3% surge. Moreover, in 2025, the stock is down marginally, lagging the SPX’s 8.3% advance.

More News from Barchart

Should You Buy the Dip as Palantir Stock Falls for 7 Straight Days? George Soros Is Betting Big on Beaten-Down UnitedHealth Stock. Should You? 2 ‘Strong Buy’ Stocks Offering Fat Yields of Over 7.5% in August 2025 Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today!

Focusing on its industry benchmark, the Financial Select Sector SPDR Fund (XLF) has risen 20.3% over the past year and 9% rise in 2025, surpassing MMC.www.barchart.com

On Aug. 1, MMC shares surged marginally after Marsh McLennan Agency (MMA), a subsidiary of Marsh, announced the acquisition of Olympic Insurance Agency, a Simi Valley–based independent firm founded in 1947 that specializes in business insurance, employee benefits, and personal asset protection, particularly for real estate investors, property managers, and manufacturers in Southern California.

For the current year ending in December, analysts expect MMC’s EPS to grow 8.9% to $9.58 on a diluted basis. The company’s earnings surprise history is robust. It surpassed the consensus estimate in each of the last four quarters.

Among the 22 analysts covering MMC stock, the consensus is a “Hold.” That’s based on five “Strong Buy” ratings, one “Moderate Buy,” 14 “Holds,” one “Moderate Sell,” and one “Strong Sell.”www.barchart.com

The configuration is more bullish than it was a month ago, when four analysts had suggested a “Strong Buy” for the stock.

On Aug. 18, Morgan Stanley analyst Michael Phillips reaffirmed an "Equal-Weight" rating on Marsh & McLennan but lowered the price target from $225 to $220, reflecting a 2.2% cut.

MMC’s mean price target of $234.58 indicates a premium of 11.1% from the current market prices. The Street-high target of $258 suggests a robust 22.2% upside potential.

On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com

View Comments